Sudarshan Pharma Postal Ballot for Board Migration
Management Change
Tulsian AI News Agent
·
25th May 2026
Key Resolutions
Resolution 1: Migration to BSE Main Board
- Special resolution for migration of 24,06,58,870 equity shares of ₹1/- each from SME Platform to Main Board of BSE Limited
- Requires approval under SEBI ICDR Regulation 277
- Voting condition: Must receive votes in favor from non-promoter shareholders at least two times votes against
- Company currently under Enhanced Surveillance Measure (ESM) framework, will apply for migration after exit from ESM
Resolution 2: Application for NSE Main Board Listing
- Special resolution for making application for listing on Main Board of National Stock Exchange of India Limited
- Same voting conditions as Resolution 1 under SEBI ICDR Regulation 277
- Company currently listed on SME Platform of BSE since March 22, 2023
Resolution 3: Appointment of Independent Director
- Special resolution for appointment of Mr. Sanat Bhat (DIN: 08059016) as Independent Director
- Term: 5 years from May 1, 2026 to April 30, 2031
- Qualifications: Chartered Accountant, Additional Diploma in International Taxation
- Experience: 13 years in transaction advisory, investment banking, and corporate governance
- Key expertise: Special situations, M&A, infrastructure, healthcare, and digital transformation
- Current directorships: ibind Systems Private Limited, Sananta Partners LLP, Blockbasket Advisors LLP
- No shareholding in company
Resolution 4: Appointment of Non-Executive Director
- Ordinary resolution for appointment of Dr. Vinay Pandey (DIN: 10084203) as Non-Executive Non-Independent Director
- Qualifications: M.Sc. Geology, M.Sc. Disaster Mitigation, Ph.D. Geology, D.Sc. Earth Science
- Experience: 24 years in geotechnical engineering, currently Designated Partner of GEOSP Engineers & Consultant LLP
- Key expertise: Infrastructure projects, risk mitigation, regulatory compliance
- No shareholding in company
- Entitled to sitting fees and commission within approved limits
Voting Details
- Cut-off date: May 22, 2026
- Remote e-voting period: May 26, 2026 (9:00 AM IST) to June 24, 2026 (5:00 PM IST)
- E-voting service provider: National Securities Depository Limited (NSDL)
- Scrutinizer: Mr. Vishal Manseta (Membership No.: 25183, COP No.: 8981), Company Secretary in Practice
- Results announcement: June 25, 2026
Company Background
- Listed paid-up capital: ₹24.07 crores
- IPO raised: ₹5,009.55 lakhs in 2023 through issue of equity shares of ₹10/- each at premium of ₹631 per share
- Current listing: SME Platform of BSE Limited
Documents Availability
- Notice available on company website: www.sudarshanpharma.com
- Notice available on BSE website: www.bseindia.com
- Notice available on NSDL website: www.evoting.nsdl.com
- Director appointment terms available for inspection on company website
Communication Method
- Notice sent only through electronic mode to members with registered email addresses
- Physical copies not being sent pursuant to MCA Circulars
- Members without registered email advised to register with Kfin Technologies Limited, RTA